CD274 and pancreatic neoplasm: For patients with metastatic colorectal cancer (mCRC), soluble PD-1, similar to soluble PD-L1, was linked to clinically worse levels of various peripheral blood parameters and metastatic tumor burden (56) and predicted systemic inflammation in pancreatic cancer (65).